A Phase I Dose Escalation Study To Evaluate Safety And Tolerability Of Cabazitaxel (Cbz) As A Single Agent In Patients (Pts) With Advanced Gastric Adenocarcinoma Who Have Failed Prior Chemotherapy (Ct) Regimens (Gastana).